| Warning:  Undefined variable $zfal in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
 
 Deprecated:  str_replace(): Passing null to parameter #3 ($subject) of type array|string is deprecated in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
 
  
 Warning:  Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 530
 
 Warning:  Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 531
 
 Warning:  file_get_contents(http://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&id=19826177&cmd=llinks): Failed to open stream: HTTP request failed! HTTP/1.1 429 Too Many Requests
 in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 445
 
   English Wikipedia
 
 Nephropedia Template TP (
 
 Twit Text
 
 
 DeepDyve
 Pubget Overpricing
 | lüll   
 
 Helicobacter pylori infection in gastric cancerogenesis Konturek PC; Konturek SJ; Brzozowski TJ Physiol Pharmacol  2009[Sep]; 60 (3): 3-21Gastric cancer (GS) remains one of the most common cancers worldwide. It is  considered as the second most frequent cause of cancer death worldwide, although  much geographical variation in incidence exists. Many studies before linked  Helicobacter pylori (Hp) which is now considered as an important pathogen, to the  risk of developing noncardia GS. This overview attempts to summarize the recent  basic and clinical evidence on the link between H. pylori and gastric cancer,  after the award of the Nobel Prize for Physiology or Medicine to Drs. J.R. Warren  and B.J. Marshall for the first culture and isolation of Hp and the investigation  of their relevance to peptic ulcer disease. It become evident that Hp eradication  by antibiotic treatment combined with proton pump inhibitor (PPI) serves as the  primary chemoprevention strategy to reduce gastric cancer incidence. Moreover,  the eradication therapy reduces gastric cancer incidence in patients without any  precancerous lesions at the baseline and is most effective before the development  of atrophic gastritis. Due to understanding the molecular nature of GC which has  been nowadays under intense investigation, our review attempts to highlight  recent progress in the field of research on Hp-induced GS. We discuss the  geographical diversity in Hp infection and cancer incidence and the mechanistic  role of gastrin, cyclooxygenase-2 (COX-2), growth factor, nitric oxide (NO)/NO  synthase and E-cadherin/beta-cathenin systems, apoptosis and angiogenesis in  Hp-induced gastric carcinogenesis. In addition host-related genetic  susceptibility and the role of overexpression of a proinflammatory cytokines and  their polymorphism is discussed in the relation to the cascade of events such as  gastric atrophy, intestinal metaplasia and dysplasia that finally lead to  adenocarcinoma.|Animals[MESH]|Gastric Mucosa/immunology/metabolism/microbiology/pathology[MESH]|Gastrins/metabolism[MESH]|Helicobacter Infections/*complications/drug  therapy/immunology/metabolism/microbiology[MESH]|Helicobacter pylori/drug effects/genetics/isolation & purification/*pathogenicity[MESH]|Humans[MESH]|Prevalence[MESH]|Stomach Neoplasms/epidemiology/*etiology/immunology/metabolism/prevention &  control[MESH]|Virulence[MESH]
 |